American Beacon ARK Transformational Innovation Fd;R6
ADNRX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- FORT WORTH TX 76155 Albany NY United States of America 12207
- IPO Date
- Oct 29, 2020
- CIK
- 0000809593
- Website
- adirondackfunds.com
- Similar Companies
- Business
- American Beacon ARK Transformational Innovation Fund (ADNRX) is an actively managed open-end mutual fund that seeks long-term capital appreciation by investing primarily in domestic and foreign equity securities of companies relevant to transformational innovation themes, including artificial intelligence, robotics, energy storage, DNA sequencing, and blockchain technology. The fund offers investors exposure to high-growth companies across these disruptive sectors through a portfolio that typically holds 30 to 50 positions, with no restrictions on market capitalization or geography; it emphasizes companies poised to benefit from technological advancements and innovation-driven market shifts. Managed by ARK Invest in sub-advisory capacity for American Beacon Advisors, Inc., the fund provides share classes including institutional (ADNRX), investor (ADNPX), and C shares (ADNCX), with daily liquidity and a focus on long-term holding periods exceeding five years. The fund operates globally, targeting innovative companies in the United States, Europe, Asia, and emerging markets, serving institutional and retail investors seeking thematic equity exposure. American Beacon Advisors, Inc., headquartered in Dallas, Texas, launched the fund in February 2021 as part of its suite of actively managed strategies distributed through broker-dealers, financial advisors, and retirement platforms. It maintains no subsidiaries but leverages ARK Invest's proprietary research platform for security selection and portfolio construction. In recent developments, the fund underwent a ticker symbol change in 2023 from its original designation to ADNRX for the institutional class, reflecting administrative updates amid growing assets under management exceeding $100 million as of late 2025. ARK Invest, the sub-advisor, announced strategic enhancements to its innovation ETF suite in 2024, indirectly benefiting the fund through refined research methodologies and new holdings in genomics and precision therapies; no major acquisitions or funding rounds apply as it is a mutual fund structure. The fund continues to adapt its portfolio amid market volatility, with increased allocations to AI infrastructure providers following the 2024-2025 tech rally.